Seer IncSEER
Market Cap: $101M
About: Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.
Employees: 147
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
2% more funds holding
Funds holding: 87 [Q1] → 89 (+2) [Q2]
9% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 23
0% more funds holding in top 10
Funds holding in top 10: 1 [Q1] → 1 (+0) [Q2]
6.33% less ownership
Funds ownership: 62.88% [Q1] → 56.55% (-6.33%) [Q2]
20% less capital invested
Capital invested by funds: $72.6M [Q1] → $57.9M (-$14.8M) [Q2]
52% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 33
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
1 analyst rating
Morgan Stanley Yuko Oku 0 / 0 met price target | 83%upside $3 | Equal-Weight Maintained | 13 Aug 2024 |
Financial journalist opinion
Based on 3 articles about SEER published over the past 30 days